Recormon_ 30 000 Iu/0.6 M_ Injection IU/0.6 m_ Injection
PDF Leaflet Revision Date: 12 August 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of renal anaemia and prevention of anaemia of prematurity.
Dosage (summary)
Initial: 3 x 20 IU/kg/week (subcutaneous); max: 720 IU/kg/week.
Onset of Action / Duration
Onset: 12-28 hours, Duration: 4-28 hours.
Special Populations
- Renal impairment
- Cancer patients
- Premature infants
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation.
Contraindications
- Hypersensitivity to epoetin beta
- Poorly controlled hypertension
- Recent myocardial infarction or stroke
Common side effects
- Hypertension
- Headache
- Thromboembolic events
Counselling Points
- Monitor haemoglobin and platelets regularly
- Avoid use in pregnancy
- Report any severe headaches or vision changes
Serious warnings
- Increased mortality in cancer patients
- Monitor blood pressure
- Risk of Pure Red Cell Aplasia
Important Disclaimer
The Recormon_ 30 000 Iu/0.6 M_ Injection IU/0.6 m_ Injection professional information leaflet below is the property of Roche Products and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
